Compare GFI & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFI | GEHC |
|---|---|---|
| Founded | 1887 | 1892 |
| Country | South Africa | United States |
| Employees | 6560 | N/A |
| Industry | Precious Metals | Computer Software: Prepackaged Software |
| Sector | Basic Materials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.5B | 32.1B |
| IPO Year | N/A | 2022 |
| Metric | GFI | GEHC |
|---|---|---|
| Price | $49.17 | $73.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 12 |
| Target Price | $45.57 | ★ $89.67 |
| AVG Volume (30 Days) | 3.3M | ★ 3.4M |
| Earning Date | 03-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.90% | 0.19% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $41.36 | $7.06 |
| Revenue Next Year | N/A | $4.50 |
| P/E Ratio | $25.02 | ★ $16.05 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $20.90 | $59.95 |
| 52 Week High | $61.52 | $89.77 |
| Indicator | GFI | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.50 | 50.45 |
| Support Level | $48.33 | $69.58 |
| Resistance Level | $53.26 | $75.33 |
| Average True Range (ATR) | 2.13 | 1.76 |
| MACD | 1.00 | 0.67 |
| Stochastic Oscillator | 72.96 | 83.13 |
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).